SAN FRANCISCO, September 14, 2017
SAN FRANCISCO, September 14, 2017 /PRNewswire/ --
The global isothermal nucleic acid amplification technology (INAAT) market is expected to reach USD 4.3 billion by 2025, growing at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. This can be attributed to significant rise in awareness regarding need for rapid and on-time testing for chronic and infectious diseases. Global increase in adoption of INAAT for detection of HIV, hepatitis A & B, and sexually transmitted diseases is considered to be a high impact rendering driver for growth.
Loop-Mediated Isothermal Amplification is one of the most preferred nucleic acid amplification methods because of its ability to provide point of care testing, thus leading to increased adoption. The recently-introduced Nicking Enzyme Amplification Reaction (NEAR) and Helicase-dependent amplification (HDA) technologies are expected to experience exponential growth during the forecast period owing to their patent protection.
In addition, owing to recent epidemics of infectious diseases, such as tuberculosis, Zika virus, and influenza, importance of point of care diagnosis has increased especially in developing countries. This is also anticipated to boost demand for this technology in these regions.
Browse full research report with TOC on "Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis By Product, By Technology (NASBA, HDA, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-inaat-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global INAAT market on the basis of product, technology, application, end-use, and region:
Read Our Blog By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519